We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News   Oct 17, 2019 | Original story from VHIO

 
Developing Pioneering Cell Therapies for Immunotherapy Non-responders

J Clin Invest. 2019. https://doi.org/10.1172/JCI127967. VHIO/created with BioRender.

 
 
 

RELATED ARTICLES

Role for Dopamine in Gene Transcription and Cell Proliferation

News

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study.

READ MORE

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

Could Mimicking How Astronauts Prep for Spaceflight Benefit Cancer Patients?

News

Researchers think that by mimicking an astronaut's schedule of exercising before, during, and after a mission, cancer patients could reduce the long-term impact their treatments can have on their bodies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE